Taurine के लिए Nighttime Pain-Related Sleep Disruption
B संबंधित साक्ष्य कम से कम एक यादृच्छिक परीक्षण इसका समर्थन करता है, जिसके परिणाम अधिकतर सुसंगत हैं।Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'sleepcited.com';
const params = 'ingredient\u003Dtaurine\u0026condition\u003Dnighttime\u002Dpain\u002Dsleep';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
निष्कर्ष
Based on 9 studies (1 meta-analysis) with 32 total participants. Results are mixed across studies.
Key Study Findings
Controlled Clinical Trial
n=32
12 weeks
Open-label
Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness …
Dose: None
बनाम: Standard care alone
Outcome: Itch and insomnia improvement in atopic dermatitis
प्रभाव: None
0.0449 (itch), 0.0089 (insomni
जनसंख्या: Patients with atopic dermatitis and mild-moderate negative emotions
Other
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
p < .05
जनसंख्या: Insomnia patients
Review
Commonly encountered symptoms and their management in patients with cirrhosis.
Dose: None
बनाम: None
Outcome: Pain outcomes
प्रभाव: None
None
जनसंख्या: Insomnia patients
Observational Study
[Energy drink consumption patterns and its adverse effects on adolescent health.].
Dose: None
बनाम: None
Outcome: Energy drink consumption and adverse effects
प्रभाव: None
None
जनसंख्या: Adolescents
Other
[Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum …
Dose: None
बनाम: None
Outcome: rat model of cardiorenal insomnia from in vitro …
प्रभाव: None
None
जनसंख्या: None
Review
Assessment and treatment of insomnia in adult patients with alcohol use disorders.
Dose: None
बनाम: None
Outcome: None
प्रभाव: None
None
जनसंख्या: insomnia patients
Key Statistics
9
अध्ययन
32
प्रतिभागी
↔
Mixed
B
ग्रेड
Referenced Papers
Asian Pacific journal …
2025
6 उद्धरण
Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors.
Other
PloS one
2024
5 उद्धरण
Frontiers in medicine
2024
4 उद्धरण
Revista espanola de …
2022
2 उद्धरण
Zhongguo Zhong yao …
2020
5 उद्धरण
Alcohol (Fayetteville, N.Y.)
2015
122 उद्धरण
British journal of …
2014
111 उद्धरण
Alcohol and alcoholism …
2011
40 उद्धरण
Journal of the …
2008
300 उद्धरण
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
सामान्य रूप से उपयोग की जाने वाली खुराकें
- sleep:
- 500-2,000 mg, 1 hour before bed
अधिकतम सीमा: 3,000 mg/day considered safe in clinical studies
अनुसंधान में अध्ययन की गई खुराकें
| खुराक | अवधि | प्रभाव | N |
|---|---|---|---|
| None | 12 weeks | Positive | 32 |
| None | -- | Neutral | -- |
| None | -- | Neutral | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
सेवन का सर्वोत्तम समय: 1 hour before bed
Safety & Side Effects
रिपोर्ट किए गए दुष्प्रभाव
- ⚠ Generally well tolerated
- ⚠ Mild GI discomfort at high doses
- ⚠ Drowsiness (desired for sleep use)
ज्ञात अंतःक्रियाएँ
- ● Lithium — taurine may alter lithium excretion
- ● Antihypertensives — may have additive blood pressure lowering effects
- ● CNS depressants — potential additive sedative effects
सहनीय अधिकतम सेवन: 3,000 mg/day considered safe in clinical studies
कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।
Frequently Asked Questions
Does Taurine help with Nighttime Pain-Related Sleep Disruption?
Based on 9 studies with 32 participants, there is moderate evidence from clinical studies that Taurine may support Nighttime Pain-Related Sleep Disruption management. Our evidence grade is B (Good Evidence).
How much Taurine should I take for Nighttime Pain-Related Sleep Disruption?
Studies have used various dosages. A commonly studied range is 500-2,000 mg, 1 hour before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Taurine?
Reported side effects may include Generally well tolerated, Mild GI discomfort at high doses, Drowsiness (desired for sleep use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Taurine and Nighttime Pain-Related Sleep Disruption?
We rate the evidence as Grade B (Good Evidence). This rating is based on 9 peer-reviewed studies with 32 total participants. The overall direction of effect is mixed.
Related Evidence
Taurine अन्य स्वास्थ्य स्थितियों के लिए
References
- [1] Wanying Zhai et al.. Asian Pac J Allergy Immunol. 2025. Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. doi:10.12932/AP-100223-1542 PubMed
- [2] Williams Kobik et al.. PLoS One. 2024. Energy drinks in Tamale: Understanding youth perceptions, consumption patterns, and related factors. doi:10.1371/journal.pone.0289391 PubMed
- [3] Cyriac Abby Philips. Front Med (Lausanne). 2024. Commonly encountered symptoms and their management in patients with cirrhosis. doi:10.3389/fmed.2024.1442525 PubMed
- [4] Paola Silva Maldonado et al.. Rev Esp Salud Publica. 2022. [Energy drink consumption patterns and its adverse effects on adolescent health.]. PubMed
- [5] Yu-Han Yang et al.. Zhongguo Zhong Yao Za Zhi. 2020. [Establishment of rat heart-kidney insomnia model consistent with traditional Chinese medicine syndrome and its serum metabolomics]. doi:10.19540/j.cnki.cjcmm.20190524.502 PubMed
- [6] Kirk J Brower. Alcohol. 2015. Assessment and treatment of insomnia in adult patients with alcohol use disorders. doi:10.1016/j.alcohol.2014.12.003 PubMed
- [7] Nicola J Kalk et al.. Br J Clin Pharmacol. 2014. The clinical pharmacology of acamprosate. doi:10.1111/bcp.12070 PubMed
- [8] Bhanu Prakash Kolla et al.. Alcohol Alcohol. 2011. Pharmacological treatment of insomnia in alcohol recovery: a systematic review. doi:10.1093/alcalc/agr073 PubMed
- [9] Kevin A Clauson et al.. J Am Pharm Assoc (2003). 2008. Safety issues associated with commercially available energy drinks. doi:10.1331/JAPhA.2008.07055 PubMed
FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।